Trial site
Groupement Des Hopitaux De L'Institut Catholique De Lille
- 16running trials
- 9closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Rheumatoid arthritis6 trials
- Gout4 trials
- Stroke2 trials
- Ankylosing spondylitis1 trial
- Atopic dermatitis (eczema)1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Diffuse large B-cell lymphoma1 trial
- and 7 more
- Phase
- Phase 315 trials
- Phase 25 trials
- Phase 44 trials
- Phase 11 trial
- Status
- Completed9 trials
- Recruiting8 trials
- Active, not recruiting5 trials
- Not yet recruiting3 trials
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris2 trials
- Assistance Publique Hopitaux De Paris2 trials
- Centre Hospitalier Universitaire Amiens Picardie2 trials
- AstraZeneca1 trial
- Bayer1 trial
- and 17 more
Running trials
Not yet recruiting
Not yet recruiting
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Recruiting
Recruiting
Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
Active, not recruiting
Active, not recruiting
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Rheumatoid arthritis5 recruiting
- Ankylosing spondylitis1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Gout1 recruiting
- Psoriasis1 recruiting
- Stroke1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Terminated
A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA
Suspended
Completed
Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026